Cutis Laxa clinical trials
18 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Safety and Effectiveness Evaluation of the High-intensity Focused Ultrasound Device for Lifting Lax Submental and Neck Tissue
- Study to Evaluate the Safety and Efficacy of the Cytrellis Micro-Coring Device for the Treatment of Moderate to Severe Facial Wrinkles
- Evaluation of Fractional Ablative Laser Treatment for Skin Conditions
- Long-Term Efficacy and Duration of MFU-V at Multiple Depths and at 1.5 mm
- Treatment to Lift Facial Lax Skin and Improve Facial Wrinkles Using Precise and Lift Applicators
- Pure Impact Treatment to Strengthen and Tone Abdomen, Quadriceps and Glutes Muscles
- A Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive Imaging
- A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment
- Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists
- Evaluate the Safety and Efficacy of AGE Serum in Post-menopausal Patients on Hormone Replacement Therapy Taking Glucagon-like Peptide-1 Agonist
- Assess Impact of Poly-L-lactic Acid on GLP1 Subjects
- Randomized Trial of Combination Treatment With Sofwave and Sculptra
- Evaluate the Safety and Efficacy of a Topical Serum (AGE Serum) in Improving Visible Signs of Aging
- Assess Impact of Microdroplet Hyaluronic Acid Filler on Skin Quality in Patients on Glucagon-like Peptide-1 Agonists
- Evaluation of SofWave Sofware-Guided Energy Delivery for Lower Face and Neck Rejuvenation
- Micro-Coring® for the Treatment of Skin Laxity of the Knees
- Safety and Efficacy of Matrix Pro for Eyebrow Lift and Lift of Submental/Neck Laxity
- Feasibility Study to Collect and Assess Safety Data for a Radiofrequency Microneedling Device for Electrocoagulation and Hemostasis of Soft Tissues for Dermatologic Conditions
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Cutis Laxa” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.